Author

Eric Fabbrizio

Centre National de la Recherche ScientifiqueORCID 0000-0002-2744-3149Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Eric Fabbrizio1 paper · IRCM, Univ Montpellier, ICM, INSERM, Montpellier, France;

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Alba SantosiD· 2 shared Antonio MaraveriD· 2 shared Céline Bouclier· 2 shared David Bracquemond· 2 shared Hélène TourrièreiD· 2 shared Laura Papon· 2 shared Luis G Paz-AresiD· 2 shared Luis M. MontuengaiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alba SantosORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MDM2 stabilization of Notch intracellular domain upon DNA damage plays a major role in non-small cell lung carcinoma response to platinum chemotherapy

Sara Bernardo, Lisa J. Brunet, Quentin Dominique Thomas, David Bracquemond, Céline Bouclier, Marie Colomb, Maicol Mancini, Eric Fabbrizio, Alba Santos, Sylvia Fenosoa Rasamizafy, Amina-Milissa Maacha, Anais Giry, Emilie Bousquet, Laura Papon, Marion Goussard, , Antonio Maraver

This study identifies MDM2 stabilization of NICD in response to platinum chemotherapy in NSCLC, showing that targeting MDM2 and NICD improves survival and reduces tumor growth.

EMBO Molecular Medicine · Jan 16, 2026Peer-reviewedCancer Biology

FMO4 drives lung adenocarcinoma by stabilizing the MAT2A/MAT2B complex and hindering ferroptosis

David Bracquemond, Sayyed Jalil Mahdizadeh, Lisa Brunet, Quentin Dominique Thomas, Céline Bouclier, Marie Colomb, Sylvia Bourdel, Eric Fabbrizio, Hélène Tourrière, Laura Papon, Xavier Quantin, Alba Santos, Irene Ferrer, Sylvain Henry, Marie Grosgeorges, , Antonio Maraver

This study identifies FMO4 as a driver of lung adenocarcinoma by stabilizing the MAT2A/MAT2B complex and inhibiting ferroptosis.

bioRxiv · Mar 31, 2025 · PreprintCancer Biology